J1 | Competitive acquisition program no-pay submission for a prescription number |
J2 | Competitive acquisition program, restocking of emergency drugs after emergency administration |
J3 | Competitive acquisition program (cap), drug not available through cap as written, reimbursed under average sales price methodology |
J4 | Dmepos item subject to dmepos competitive bidding program that is furnished by a hospital upon discharge |
JA | Administered intravenously |
JB | Administered subcutaneously |
JC | Skin substitute used as a graft |
JD | Skin substitute not used as a graft |
JE | Administered via dialysate |
JF | Compounded drug |
JW | Drug amount discarded/not administered to any patient |
General
Content
Integrations